Investors / Sweden / Nordic Science Capital
Nordic Science Capital
Accelerator · Solna, Sweden · Europe
Nordic Science Capital is a life science incubator that makes inception-stage bets on ideas born inside Sweden's leading universities. It co-forms companies, co-files patents, and contributes as founding executives.
Invests inHealthcare & Biotech
In its own wordsbiotechlife sciencesincubationoncologyprotein engineeringsynthetic biology
Your fit with Nordic Science Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsNordic Science Capital lists 3 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%).
No funding round on record names Nordic Science Capital yet, so the figures come from its portfolio page.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Ora Global | 1 |
| Vento | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers3100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Compare Nordic Science Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
3 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Portfolio page | ||||
| BioInferix develops a fiber-based biopsy system that uses transient state imaging to identify cancer cells in real-time and treats targeted cells with light | Healthcare & Biotech | Portfolio page | ||
| Moligo synthesizes and modifies single-stranded DNA for research and therapeutic applications | Healthcare & Biotech | Portfolio page |
About this data
site last read 12 Nov 2026- Site
- ns.capital
- Last read
- 12 Nov 2026
- Watching since
- 7 Nov 2026
- Companies checked
- 3
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Nordic Science Capital's profile as data
Pull Nordic Science Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/ns.capital
# also
GET /v1/firms/ns.capital/portfolio
GET /v1/firms/ns.capital/coinvestors
GET /v1/firms/ns.capital/news